James A. Robinson Jr. Uro Gen Pharma Ltd. (URGN) insider trading activity

James A. Robinson Jr. is Director of UroGen Pharma Ltd.. Currently has a direct ownership of 2,000 shares of URGN, which is worth approximately $48,660. The most recent transaction as insider was on Nov 26, 2025, when has been sold 2,000 shares (Ordinary Shares) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 2K

n/a 3M change

n/a 12M change

Total Value Held $48,660

James A. Robinson Jr. Transaction History

Date	Transaction	Value	Shares Traded	Shares Held	Form
Nov 26 2025	BUY Exercise of conversion of derivative security	-	2,000 Added 50.0%	2,000 Ordinary Shares

Also insider at

UROV

Urovant Sciences Ltd.

PEO;CEO/Urovant Sciences, Inc.

AGTC

APPLIED GENETIC TECHNOLOGIES CORP Healthcare

Director

ELDN

Eledon Pharmaceuticals, Inc. Healthcare

JAR